NCT06083272

Brief Summary

This is a confirmatory study without any intervention. It is an uncontrolled, non-randomized and open-label study with measurements made with comparators, and it has a preset hypothesis for the primary endpoint. There are no similar devices to VitalThings Guardian M10 / M10 mobile on the market, consequently one or more different types of devices must be used as comparators.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 8, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 13, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

November 15, 2023

Completed
13 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 28, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 28, 2023

Completed
Last Updated

December 5, 2023

Status Verified

December 1, 2023

Enrollment Period

13 days

First QC Date

October 8, 2023

Last Update Submit

December 4, 2023

Conditions

Keywords

respiratory ratepatient monitoringultra wideband radarcontactless monitoringmedical device regulation

Outcome Measures

Primary Outcomes (1)

  • Accuracy

    Documented system respiration frequency in RPM for both investigational device and comparator.

    Will be assessed after last participant has finished the investigation. One interim analysis in first week is planned.

Secondary Outcomes (1)

  • Comparative pulse data

    Will be assessed in 2024, furter details not established.

Other Outcomes (1)

  • Acceptance criteria respiratory rate

    Will be assessed after last participant has finished the investigation. One interim analysis in first week is planned.

Study Arms (1)

Study population

The study population is comprised of two subgroups; 1. Adult patients admitted to the Emergency Ward (EW). Patients are recruited after the treatment and examination in EW are finished and the patient is waiting for transfer to a hospital ward. 2. If there is a prolonged period of waiting time for a control blood sample, chest CT or any other examination which usually incurs significant waiting time in the EW. This will be evaluated by a specialist in emergency medicine based on the premise that the inclusion in the study will not delay or interfere with these examinations.

Device: Vitalthings Guardian M10 fixed and M10 mobile

Interventions

VitalThings Guardian M10 / M10 mobile (VitalThings, Norway), are the investigational devices. These are the same technical devices made in two versions: one wall-mounted (VitalThings Guardian M10 fixed) and one mounted on a trolley (VitalThings Guardian M10 mobile). The Nox T3s and Nonin will be used as comparator devices.

Also known as: Nox T3s (NOX Medical, Alpharetta, GA, USA ) with a Nonin 3150 pulse oximeter (Nonin Medical Inc., MN, USA)
Study population

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The EW study population is beneficial to the study as it offers an unfiltered study population with a broad cross-section of potential admission reasons and diagnoses in a short period of time. Any patient that needs acute treatment/examination (typically triaged as "red") will per standard of care go into dedicated EW rooms and not be part of this study. The safe participation of each patient will be evaluated by a specialist in emergency medicine (PI) before invitation to participate.

You may qualify if:

  • Adult patients admitted to the Emergency Ward (EW)

You may not qualify if:

  • Under age (below 18 years) and subjects not able to provide informed consent themselves. Subjects dismissed from the EW rooms within 30 minutes from first registration are removed from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St Olavs University Hospital

Trondheim, Norway

Location

Related Publications (1)

  • Toften S, Kjellstadli JT, Kvaerness J, Pedersen L, Laugsand LE, Thu OKF. Contactless and continuous monitoring of respiratory rate in a hospital ward: a clinical validation study. Front Physiol. 2024 Nov 27;15:1502413. doi: 10.3389/fphys.2024.1502413. eCollection 2024.

MeSH Terms

Conditions

Respiratory InsufficiencyClinical Deterioration

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesDisease ProgressionDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Line Pedersen, MD, Phd

    St. Olavs Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 8, 2023

First Posted

October 13, 2023

Study Start

November 15, 2023

Primary Completion

November 28, 2023

Study Completion

November 28, 2023

Last Updated

December 5, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations